AvantGen is an innovative biotechnology company focused on antibody discovery and optimization using its proprietary yeast display technology and robust human antibody libraries. Partnering with biopharmaceutical firms, AvantGen accelerates the development of novel therapeutic antibodies, offering deep expertise in engineering high-affinity, developable candidates against challenging biological targets.